- Home
- FIVN vs VERA Comparison
FIVN vs VERA Comparison
Compare FIVN & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIVN
- VERA
- Stock Information
- Founded
- FIVN 2001
- VERA 2016
- Country
- FIVN United States
- VERA United States
- Employees
- FIVN N/A
- VERA N/A
- Industry
- FIVN EDP Services
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- FIVN Technology
- VERA Health Care
- Exchange
- FIVN Nasdaq
- VERA Nasdaq
- Market Cap
- FIVN 2.8B
- VERA 2.4B
- IPO Year
- FIVN 2014
- VERA 2021
- Fundamental
- Price
- FIVN $42.09
- VERA $28.58
- Analyst Decision
- FIVN Strong Buy
- VERA Buy
- Analyst Count
- FIVN 17
- VERA 8
- Target Price
- FIVN $57.65
- VERA $66.38
- AVG Volume (30 Days)
- FIVN 1.6M
- VERA 985.9K
- Earning Date
- FIVN 02-20-2025
- VERA 03-19-2025
- Dividend Yield
- FIVN N/A
- VERA N/A
- EPS Growth
- FIVN N/A
- VERA N/A
- EPS
- FIVN N/A
- VERA N/A
- Revenue
- FIVN $1,041,938,000.00
- VERA N/A
- Revenue This Year
- FIVN $15.54
- VERA N/A
- Revenue Next Year
- FIVN $10.46
- VERA N/A
- P/E Ratio
- FIVN N/A
- VERA N/A
- Revenue Growth
- FIVN 14.44
- VERA N/A
- 52 Week Low
- FIVN $26.60
- VERA $25.99
- 52 Week High
- FIVN $64.70
- VERA $51.61
- Technical
- Relative Strength Index (RSI)
- FIVN 56.09
- VERA 29.57
- Support Level
- FIVN $40.02
- VERA $25.99
- Resistance Level
- FIVN $43.62
- VERA $34.79
- Average True Range (ATR)
- FIVN 2.08
- VERA 2.15
- MACD
- FIVN 0.06
- VERA -0.56
- Stochastic Oscillator
- FIVN 26.67
- VERA 20.05
About FIVN Five9 Inc.
Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement, and various modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, as well as workforce optimization solutions that optimize call center efficiency, and manage interaction quality and agent performance.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.